TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hua Medicine ( (HK:2552) ) has provided an update.
Hua Medicine has announced that its board of directors will meet on August 28, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will determine the company’s financial performance and potentially impact its market positioning and stakeholder confidence.
More about Hua Medicine
Hua Medicine is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on developing innovative therapies and is publicly listed on the Hong Kong Stock Exchange.
YTD Price Performance: 139.04%
Average Trading Volume: 9,966,170
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.39B
See more data about 2552 stock on TipRanks’ Stock Analysis page.